Caribou Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.23

-0.01 (-0.81%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +556.9% upside

Low Target $6.79

Average Target $8.08

High Target $13.52

Current Price $1.23

Current
$1.23

Target
$8.08

$6.79 $8.08 avg $13.52

Scenario Analysis

Bear Case

$6.79

452.0%

Low target

Base Case

$8.08

+556.9%

Avg target

Bull Case

$13.52

+999.2%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$3.54

-65.2% from high

52-Week Low

$1.25

+-1.6% from low

Target vs 52W High

$8.08

+128.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%